Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells
- 8 July 2021
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 22 (8) , 947-957
Abstract
One of most challenging issues in tumor immunology is a better understanding of the dynamics in the accumulation of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment (TIME), as this would lead to the development of new cancer therapeutics. Here, we show that translationally controlled tumor protein (TCTP) released by dying tumor cells is an immunomodulator crucial to full-blown MDSC accumulation in the TIME. We provide evidence that extracellular TCTP mediates recruitment of the polymorphonuclear MDSC (PMN-MDSC) population in the TIME via activation of Toll-like receptor-2. As further proof of principle, we show that inhibition of TCTP suppresses PMN-MDSC accumulation and tumor growth. In human cancers, we find an elevation of TCTP and an inverse correlation of TCTP gene dosage with antitumor immune signatures and clinical prognosis. This study reveals the hitherto poorly understood mechanism of the MDSC dynamics in the TIME, offering a new rationale for cancer immunotherapy.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (Scientific Research (A), 20298458, Scientific Research (S) 15638461, Young Scientist 18030848, Research Fellowship for Young Scientists 19J00887)
- The Uehara Memorial Foundation and the Takeda Science Foundation
- Japan Agency for Medical Research and Development (AMED-PRIME 1005352)
- The Naito Foundation
This publication has 57 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cellsJournal of Experimental Medicine, 2011
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cellsProceedings of the National Academy of Sciences, 2011
- Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapyJournal of Experimental Medicine, 2010
- Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluationBritish Journal of Cancer, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Dimerization of Translationally Controlled Tumor Protein Is Essential For Its Cytokine-Like ActivityPLOS ONE, 2009
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Human fortilin is a molecular target of dihydroartemisininFEBS Letters, 2008
- DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune responseNature, 2007